Bal Pharma Limited Share Price & Analysis
₹86.23▼ -1.01%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹86.23
-1.01%
Open
₹—
High
₹91.4
Low
₹85
Close
₹86.23
52W High
₹113
52W Low
₹59.7
Volume
56K
Lot Size
1
Sector
Healthcare
Market Cap
₹139 Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
22.1
Sector P/E
48.9
P/B
1.67
EPS
₹5.11
ROE
7.87%
ROCE
9.69%
D/E Ratio
1.95
Div Yield
1.37%
Book Value
₹51.6
+
Strengths
- ✓Attractively valued vs sector (P/E 22.1x vs industry 48.9x)
−
Concerns
- ✗Elevated debt levels (D/E 2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BALPHARMA · as of Mar 2026
Promoters50.87%
FII0.14%
Public49.01%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 51.24% | 51.24% | 51.24% | 50.87% | 50.87% | 50.87% |
| FII | 0.13% | 0.13% | 0.13% | 0.13% | 0.14% | 0.14% |
| Public | 48.64% | 48.64% | 48.63% | 49.01% | 49.00% | 49.01% |
Corporate Events
To consider and approve the audited financial results for the period ended March 31, 2026, dividend and other business matters
Dividend26 May 2026
Dividend - Rs 1.20 Per Share
Dividend17 Sept 2025
Annual General Me0etingdividend - Rs 1.2 Per Share
Dividend16 Sept 2024
Annual General Meeting/Dividend - Re 1 Per Share
Dividend17 Sept 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹87.69 Cr ▲18.5% | ₹74.02 Cr ▲12.4% | ₹65.87 Cr ▼19.6% | ₹81.88 Cr ▲11.9% | ₹73.15 Cr ▼0.7% | ₹73.69 Cr ▼0.9% | ₹74.36 Cr ▼21.4% | ₹94.63 Cr |
| Op. Profit | ₹9.54 Cr ▲66.5% | ₹5.73 Cr ▼5.4% | ₹6.06 Cr ▼20.7% | ₹7.64 Cr ▼1.4% | ₹7.75 Cr ▲0.8% | ₹7.69 Cr ▲18.9% | ₹6.47 Cr ▼32.6% | ₹9.6 Cr |
| OPM | 10.9% ▲40.6% | 7.7% ▼15.9% | 9.2% ▼1.4% | 9.3% ▼11.9% | 10.6% ▲1.4% | 10.4% ▲20.0% | 8.7% ▼14.2% | 10.1% |
| Net Profit | ₹1.79 Cr ▲148.6% | ₹0.72 Cr ▲242.9% | ₹0.21 Cr ▼96.1% | ₹5.41 Cr ▲940.4% | ₹0.52 Cr ▼50.0% | ₹1.04 Cr ▲300.0% | ₹0.26 Cr ▼95.3% | ₹5.53 Cr |
| EPS (₹) | 1.12 ▲148.9% | 0.45 ▲246.2% | 0.13 ▼96.2% | 3.41 ▲1036.7% | 0.3 ▼53.8% | 0.65 ▲306.3% | 0.16 ▼95.4% | 3.46 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹312 Cr ▲3.0% | ₹303 Cr ▼10.6% | ₹339 Cr ▲11.5% | ₹304 Cr ▲8.2% | ₹281 Cr ▲12.0% | ₹251 Cr ▲46.8% | ₹171 Cr ▼24.0% | ₹225 Cr ▲6.6% | ₹211 Cr ▼7.9% | ₹229 Cr |
| Expenses | ₹280 Cr ▲2.6% | ₹273 Cr ▼11.4% | ₹308 Cr ▲10.4% | ₹279 Cr ▲8.6% | ₹257 Cr ▲13.7% | ₹226 Cr ▲36.1% | ₹166 Cr ▼19.8% | ₹207 Cr ▲6.7% | ₹194 Cr ▼9.3% | ₹214 Cr |
| Op. Profit | ₹32 Cr ▲6.7% | ₹30 Cr ▼3.2% | ₹31 Cr ▲24.0% | ₹25 Cr ▲4.2% | ₹24 Cr ▼4.0% | ₹25 Cr ▲400.0% | ₹5 Cr ▼72.2% | ₹18 Cr ▲5.9% | ₹17 Cr ▲13.3% | ₹15 Cr |
| OPM | 10.0% ▲0.0% | 10.0% ▲11.1% | 9.0% ▲12.5% | 8.0% ▼11.1% | 9.0% ▼10.0% | 10.0% ▲233.3% | 3.0% ▼62.5% | 8.0% ▲0.0% | 8.0% ▲33.3% | 6.0% |
| Other Income | ₹2 Cr ▲0.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▲200.0% | ₹1 Cr ▼80.0% | ₹5 Cr ▲400.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▼33.3% | ₹3 Cr |
| Interest | ₹17 Cr ▲0.0% | ₹17 Cr ▲13.3% | ₹15 Cr ▲25.0% | ₹12 Cr ▲9.1% | ₹11 Cr ▼8.3% | ₹12 Cr ▼7.7% | ₹13 Cr ▲0.0% | ₹13 Cr ▲44.4% | ₹9 Cr ▲12.5% | ₹8 Cr |
| Depreciation | ₹11 Cr ▲10.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲11.1% | ₹9 Cr ▲0.0% | ₹9 Cr ▼10.0% | ₹10 Cr ▲25.0% | ₹8 Cr ▲33.3% | ₹6 Cr ▼14.3% | ₹7 Cr ▲16.7% | ₹6 Cr |
| PBT | ₹6 Cr ▲20.0% | ₹5 Cr ▼44.4% | ₹9 Cr ▲80.0% | ₹5 Cr ▼44.4% | ₹9 Cr ▲125.0% | ₹4 Cr ▲128.6% | ₹-14 Cr | ₹0 Cr ▼100.0% | ₹3 Cr ▲0.0% | ₹3 Cr |
| Tax % | -7.0% ▲82.9% | -41.0% ▼327.8% | 18.0% ▼60.0% | 45.0% ▲18.4% | 38.0% ▲353.3% | -15.0% ▼200.0% | -5.0% ▲99.6% | -1175.0% ▼1450.6% | 87.0% ▼23.7% | 114.0% |
| Net Profit | ₹6 Cr ▼14.3% | ₹7 Cr ▲0.0% | ₹7 Cr ▲133.3% | ₹3 Cr ▼50.0% | ₹6 Cr ▲20.0% | ₹5 Cr ▲138.5% | ₹-13 Cr ▼750.0% | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| EPS (₹) | 3.94 ▼13.0% | 4.53 ▼3.2% | 4.68 ▲185.4% | 1.64 ▼56.6% | 3.78 ▲18.1% | 3.2 ▲137.1% | -8.62 ▼422.8% | 2.67 ▲36.2% | 1.96 ▲58.1% | 1.24 |
| Div Payout | 0.0% ▼100.0% | 26.0% ▲0.0% | 26.0% ▼57.4% | 61.0% ▲134.6% | 26.0% ▼16.1% | 31.0% | 0.0% ▼100.0% | 37.0% ▼27.5% | 51.0% ▼37.0% | 81.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹16 Cr ▲0.0% | ₹16 Cr ▲0.0% | ₹16 Cr ▲0.0% | ₹16 Cr ▲6.7% | ₹15 Cr ▲0.0% | ₹15 Cr ▲7.1% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr |
| Reserves | ₹62 Cr ▲0.0% | ₹62 Cr ▲10.7% | ₹56 Cr ▲16.7% | ₹48 Cr ▲9.1% | ₹44 Cr ▲12.8% | ₹39 Cr ▲2.6% | ₹38 Cr ▼26.9% | ₹52 Cr ▲2.0% | ₹51 Cr ▲6.3% | ₹48 Cr |
| Borrowings | ₹155 Cr ▲3.3% | ₹150 Cr ▲7.1% | ₹140 Cr ▲6.9% | ₹131 Cr ▲26.0% | ₹104 Cr ▼5.5% | ₹110 Cr ▼6.8% | ₹118 Cr ▼4.8% | ₹124 Cr ▲12.7% | ₹110 Cr ▲18.3% | ₹93 Cr |
| Other Liabilities | ₹116 Cr ▲7.4% | ₹108 Cr ▲0.0% | ₹108 Cr ▼6.9% | ₹116 Cr ▲18.4% | ₹98 Cr ▲28.9% | ₹76 Cr ▲11.8% | ₹68 Cr ▼4.2% | ₹71 Cr ▼17.4% | ₹86 Cr ▲10.3% | ₹78 Cr |
| Total Liabilities | ₹349 Cr ▲3.9% | ₹336 Cr ▲5.0% | ₹320 Cr ▲2.9% | ₹311 Cr ▲19.2% | ₹261 Cr ▲8.8% | ₹240 Cr ▲0.8% | ₹238 Cr ▼8.8% | ₹261 Cr ▲0.4% | ₹260 Cr ▲11.6% | ₹233 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹92 Cr ▲5.7% | ₹87 Cr ▲8.8% | ₹80 Cr ▲5.3% | ₹76 Cr ▲13.4% | ₹67 Cr ▼2.9% | ₹69 Cr ▼2.8% | ₹71 Cr ▲1.4% | ₹70 Cr ▼1.4% | ₹71 Cr ▲18.3% | ₹60 Cr |
| CWIP | ₹3 Cr ▲0.0% | ₹3 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr | ₹0 Cr ▼100.0% | ₹3 Cr ▼25.0% | ₹4 Cr | ₹0 Cr ▼100.0% | ₹2 Cr |
| Investments | ₹0 Cr ▼100.0% | ₹2 Cr ▼71.4% | ₹7 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹253 Cr ▲3.7% | ₹244 Cr ▲4.7% | ₹233 Cr ▼0.9% | ₹235 Cr ▲22.4% | ₹192 Cr ▲11.6% | ₹172 Cr ▲4.9% | ₹164 Cr ▼12.3% | ₹187 Cr ▼0.5% | ₹188 Cr ▲9.3% | ₹172 Cr |
| Total Assets | ₹349 Cr ▲3.9% | ₹336 Cr ▲5.0% | ₹320 Cr ▲2.9% | ₹311 Cr ▲19.2% | ₹261 Cr ▲8.8% | ₹240 Cr ▲0.8% | ₹238 Cr ▼8.8% | ₹261 Cr ▲0.4% | ₹260 Cr ▲11.6% | ₹233 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹20 Cr ▼13.0% | ₹23 Cr ▲1250.0% | ₹-2 Cr ▼107.4% | ₹27 Cr ▲22.7% | ₹22 Cr ▼4.3% | ₹23 Cr ▲187.5% | ₹8 Cr ▲700.0% | ₹1 Cr ▼83.3% | ₹6 Cr ▲131.6% | ₹-19 Cr |
| Investing CF | ₹-15 Cr ▲21.1% | ₹-19 Cr ▲13.6% | ₹-22 Cr ▼144.4% | ₹-9 Cr ▼50.0% | ₹-6 Cr ▼20.0% | ₹-5 Cr ▲37.5% | ₹-8 Cr ▼100.0% | ₹-4 Cr ▲50.0% | ₹-8 Cr ▲42.9% | ₹-14 Cr |
| Financing CF | ₹-8 Cr ▼700.0% | ₹-1 Cr ▼104.2% | ₹24 Cr ▲241.2% | ₹-17 Cr ▲0.0% | ₹-17 Cr ▲15.0% | ₹-20 Cr | ₹0 Cr ▼100.0% | ₹4 Cr ▲166.7% | ₹-6 Cr ▼118.8% | ₹32 Cr |
| Net Cash Flow | ₹-2 Cr ▼166.7% | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▲100.0% | ₹-2 Cr | ₹0 Cr ▼100.0% | ₹1 Cr ▲112.5% | ₹-8 Cr ▼700.0% | ₹-1 Cr |
| Free Cash Flow | ₹2 Cr ▼83.3% | ₹12 Cr ▲175.0% | ₹-16 Cr ▼188.9% | ₹18 Cr ▼5.3% | ₹19 Cr ▲5.6% | ₹18 Cr ▲1900.0% | ₹-1 Cr ▲66.7% | ₹-3 Cr ▼50.0% | ₹-2 Cr ▲94.1% | ₹-34 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 111d ▲3.7% | 107d ▼5.3% | 113d ▲15.3% | 98d ▲0.0% | 98d ▼7.5% | 106d ▲1.0% | 105d ▼5.4% | 111d ▲12.1% | 99d ▼5.7% | 105d |
| Inventory Days | 238d ▲42.5% | 167d ▼19.3% | 207d ▲27.8% | 162d ▲11.0% | 146d ▼50.0% | 292d ▲34.6% | 217d ▼9.6% | 240d ▲39.5% | 172d ▲18.6% | 145d |
| Days Payable | 189d ▲28.6% | 147d ▼12.0% | 167d ▲16.8% | 143d ▲25.4% | 114d ▼31.7% | 167d ▲13.6% | 147d ▼19.2% | 182d ▲6.4% | 171d ▲4.9% | 163d |
| Cash Conv. Cycle | 161d ▲26.8% | 127d ▼17.0% | 153d ▲30.8% | 117d ▼10.0% | 130d ▼43.7% | 231d ▲32.0% | 175d ▲4.2% | 168d ▲68.0% | 100d ▲14.9% | 87d |
| Working Capital Days | 6d ▼50.0% | 12d ▼7.7% | 13d ▼27.8% | 18d ▲63.6% | 11d ▲200.0% | -11d ▼144.0% | 25d ▼44.4% | 45d ▲73.1% | 26d ▼48.0% | 50d |
| ROCE | 10.0% ▼16.7% | 12.0% ▲20.0% | 10.0% ▼16.7% | 12.0% ▲20.0% | 10.0% | 0.0% ▼100.0% | 7.0% ▼12.5% | 8.0% ▲0.0% | 8.0% ▲14.3% | 7.0% |
Source: Screener.in · Lower days = better efficiency
About Bal Pharma Limited
Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Bal Pharma Limited share price today?▾
Bal Pharma Limited (BALPHARMA) is currently trading at ₹86.23 on NSE, down 1.01% as of the last market session. Prices update daily after market close on MarketNetra.
Is Bal Pharma Limited available in F&O (Futures & Options)?▾
Yes, Bal Pharma Limited (BALPHARMA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Bal Pharma Limited 52-week high and low?▾
Bal Pharma Limited's 52-week high is ₹113 and the 52-week low is ₹59.7. The current price of ₹86.23 is 23.7% below the 52W high.
What is Bal Pharma Limited P/E ratio?▾
Bal Pharma Limited's current P/E ratio is 22.1. This indicates the market is paying ₹22.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Bal Pharma Limited options?▾
Bal Pharma Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade BALPHARMA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.